Poster Presentations

Thursday, October 8 – Saturday, October 10, 2026

Adjuvant endocrine therapy
P01 monarchE: SUBGROUP ANALYSIS OF ADJUVANT ABEMACICLIB + ENDOCRINE THERAPY (ET) FOR HR+, HER2-, HIGH-RISK EARLY BREAST CANCER (EBC) BY NODAL STATUS
Aarohan Pruthi, Sydney, Australia
P02 LONG TERM EFFICACY OF ADJUVANT ABEMACICLIB + ENDOCRINE THERAPY (ET) IN KEY SUBGROUPS IN THE monarchE TRIAL
Catherine Shannon, Brisbane, Australia
Breast cancer genetics
P03 REAL-WORLD EVALUATION OF MAINSTREAM GERMLINE GENETIC TESTING IN PATIENTS WITH EARLY BREAST CANCER
Jenny Gilchrist, Sydney, Australia
P04 EARLY OUTCOMES OF A MAINSTREAM GERMLINE GENETIC TESTING PROGRAM FOR PATIENTS WITH BREAST CANCER: A RETROSPECTIVE COHORT STUDY FROM AN AUSTRALIAN TERTIARY HEALTH SERVICE
Annabel Goodwin, Sydney, Australia
P05 INTEGRATING DOSE MODIFICATIONS FOR EFFECTIVE MANAGEMENT OF HR+, HER2− EARLY BREAST CANCER WITH ABEMACICLIB
Aarohan Pruthi, Sydney, Australia
P06 CLINICIAN-DEVELOPED ARTIFICIAL INTELLIGENCE-ASSISTED WEB APPLICATION FOR DETERMINING ELIGIBILITY FOR MAINSTREAM BREAST CANCER GERMLINE PANEL TESTING UNDER CURRENT EVIQ GUIDELINES
Shweta Srinivasa, Sydney, Australia
Breast imaging and screening
P07 BEYOND THE SCAR: PITFALLS AND PEARLS IN POST-SURGICAL BREAST IMAGING
Vanessa Atienza-Hipolito, Perth, Australia
P08 CULTIVATING COLLABORATIVE CHANGE: CONSUMER ENGAGEMENT IN BREAST DENSITY POLICY, PRACTICE AND RESEARCH
Kym Berchtenbreiter, Melbourne, Australia
P09 FIRST-YEAR OUTCOMES OF A POPULATION-BASED BREAST CANCER SCREENING PROGRAMME AT A REGIONAL TERTIARY HOSPITAL IN SINGAPORE
Victoria Elena Chan, Woodlands, Singapore
P10 BRAIX AI 3RD READS AT MONASH BREASTSCREEN PILOT: INITIAL EXPERIENCE
Lucia Chen, Melbourne, Australia
P11 CONTRAST ENHANCED MAMMOGRAM GUIDED BIOPSIES- AN ALTERNATIVE TO MRI GUIDED BREAST BIOPSIES- A YEAR IN REVIEW
Amy Clucas, Melbourne, Australia
P12 LYMPHOID MALIGNANCY MIMICKING BREAST CANCER ON IMAGING – A PATHOLOGY PERSPECTIVE
Jespal Gill, Perth, Australia
P13 SEQUENTIAL CONTRAST-ENHANCED MAMMOGRAPHY FOLLOWING DIGITAL BREAST TOMOSYNTHESIS IMPROVES CANCER DETECTION AND BI-RADS CATEGORISATION IN PRE-OPERATIVE BREAST CANCER STAGING: A MULTI-READER STUDY
Ellie Mulyadi, Sydney, Australia
P14 CONTRALATERAL WHOLE-BREAST ULTRASOUND IN NEWLY DIAGNOSED BREAST CANCER
Carmen Prinsloo, Gold Coast, Australia
P15 FEASIBILITY OF MULTI-MODALITY IMAGE-GUIDED SCOUT® RADAR LOCALISATION FOR SURGICAL “BRACKETING” FOR BREAST CONSERVATION SURGERY: INITIAL EXPERIENCE IN AN AUSTRALIAN TERTIARY CENTRE
Coralie Simoni, Melbourne, Australia
P16 INVASIVE DUCTAL CARCINOMA ARISING WITHIN A BREAST HAMARTOMA: A CASE SERIES AND REVIEW OF THE LITERATURE
Leona Ward, Adelaide, Australia
HER2 positive breast cancer
P17 A RETROSPECTIVE ANALYSIS OF CLINICOPATHOLOGIC FEATURES ASSOCIATED WITH LONG-TERM RESPONSE TO FIRST-LINE HER2-TARGETED THERAPY IN ADVANCED OR METASTATIC HER2-POSITIVE BREAST CANCER
Lachlan Fitzpatrick, Sydney, Australia
Locoregional therapy
P18 REAL-WORLD MANAGEMENT OF INFLAMMATORY BREAST CANCER IN AUSTRALIA AND NEW ZEALAND: TREATMENT PATTERNS, GUIDELINE ADHERENCE AND PATHOLOGICAL COMPLETE RESPONSE RATES FROM A BINATIONAL QUALITY REGISTRY
Nelson Chen, Sydney, Australia
P19 COMPARISON OF 0.4ML VS 0.6ML DILUTED INDIA INK SOLUTION FOR TATTOOING OF AXILLARY LYMPH NODES IN THE PATIENT WITH BREAST CANCER: A RANDOMIZED CONTROLLED TRIAL
Mithilesh Kumar Sinha, Odisha, India
P20 OCCULT MALIGNANCY AND SENTINEL LYMPH NODE METASTASIS IN PROPHYLACTIC MASTECTOMY
Ziad Zeidan, Gold Coast, Australia
Lymphoedema
P21 FROM THUMB TO AXILLA: NECROTISING LYMPHADENITIS WITH MULTI-ORGAN FAILURE AND RESULTING LYMPHOEDEMA
Morgan Chambers, Bay of Plenty, New Zealand
P22 CLINICAL BREAST CANCER RISK FACTORS AND MANAGEMENT OF BREAST LYMPHOEDEMA AFTER BREAST-CONSERVING TREATMENT: A SCOPING REVIEW
Senarath Edirimanne, Sydney, Australia
Metastatic breast cancer
P23 DEVELOPMENT AND CONTENT VALIDATION OF A TREATMENT SUMMARY AND WELLNESS PLAN FOR PEOPLE LIVING WITH METASTATIC BREAST CANCER
Melanie Brothers, Sydney, Australia
P24 EXTRAMEDULLARY HAEMATOPOIESIS IN AXILLARY LYMPH NODES MIMICKING METASTATIC CARCINOMA OF BREAST: A POTENTIAL DIAGNOSTIC PITFALL
Jespal Gill, Perth, Australia
P25 METASTATIC LOBULAR CARCINOMA TO THE GASTROINTESTINAL TRACT MIMICKING PRIMARY GI MALIGNANCY
Jespal Gill, Perth, Australia
P26 REAL-WORLD PROGRESSION-FREE SURVIVAL (PFS) OF ABEMACICLIB + FULVESTRANT IN ER+, HER2- METASTATIC BREAST CANCER (MBC) IN US CLINICAL PRACTICE
Aarohan Pruthi, Sydney, Australia
P27 COUNTED AT LAST: LEADING CONSUMER-DRIVEN DATA REFORM TO MAKE METASTATIC BREAST CANCER VISIBLE
Helena Rodi, Melbourne, Australia
P28 FROM BENIGN APPEARING BREAST LESION TO RAPID METASTATIC DISEASE. A CASE REPORT OF A MALIGNANT PHYLLODES TUMOUR
Leona Ward, Adelaide, Australia
Neoadjuvant therapy
P29 THE EFFECT OF BODY COMPOSITION ON NEO-ADJUVANT CHEMOTHERAPY RESPONSE, TOXICITY, AND PROGNOSIS IN BREAST CANCER: A SCOPING REVIEW
Senarath Edirimanne, Sydney, Australia
P30 OUTCOMES FOR EARLY-STAGE TRIPLE-NEGATIVE BREAST CANCERS RECEIVING NEOADJUVANT SYSTEMIC TREATMENT IN TBCCpo
Siti Naemah Sahralidin, Brunei Muara, Brunei Darussalam
Oncoplastic/reconstructive surgery
P31 FAVOURABLE OBJECTIVE AESTHETIC OUTCOMES FOLLOWING CHEST WALL PERFORATOR FLAP RECONSTRUCTION
Rebecca Cui, Sydney, Australia
P32 IMMEDIATE PARTIAL BREAST RECONSTRUCTION WITH MODIFIED CHEST WALL PERFORATOR FLAPS FOR BREAST CANCER: LONGITUDINAL ONCOLOGICAL, IMAGING AND PATIENT-REPORTED OUTCOMES FROM A 50-PATIENT SERIES
Eve Hopping, Nelson South, New Zealand
P33 LOOKING BEYOND RAW IMMEDIATE BREAST RECONSTRUCTION RATES: ACCESS, PATIENT HEALTH AND CHOICE IN A PUBLIC HOSPITAL
Wadia Mubashira, Sydney, Australia
P34 CLINICAL PATHWAYS AND OUTCOMES FOLLOWING IMMEDIATE IMPLANT-BASED BREAST RECONSTRUCTION AND POST-MASTECTOMY RADIOTHERAPY: A 9-YEAR ANALYSIS
Dinushi Perera, Sydney, Australia
P35 CAN ABSORBABLE MESH REPLACE/MINIMISE THE NEED OF PEDICLED FLAPS TO RECONSTRUCT MODERATE TO LARGE SIZE DEFECT FOLLOWING BREAST CONSERVATION SURGERY; A NOVEL TECHNIQUE. PROSPECTIVE PILOT STUDY
Seema Singh, Delhi, India
P36 SECONDARY MASTOPEXY FOLLOWING IMPLANT-BASED BREAST RECONSTRUCTION: A SYSTEMATIC REVIEW
Kor Woi Tiang, Sydney, Australia
 Prevention
P37 OPIOID OVERPRESCRIBING AFTER BREAST CANCER SURGERY: A PROSPECTIVE OBSERVATIONAL STUDY FROM AN AUSTRALIAN QUATERNARY CANCER CENTRE
Su Ang, Sydney, Australia
P38 FEASIBILITY, ACCEPTABILITY, AND PRELIMINARY EFFICACY OUTCOMES FROM A PILOT RANDOMISED TRIAL OF A DIGITAL HEALTH INTERVENTION TO SUPPORT RECOVERY AFTER BREAST CANCER SURGERY
Helen Moore, Newcastle, Australia
Radiotherapy
P39 SETUP ERRORS WITH FREE BREATHING AND DEEP INSPIRATORY BREATH HOLD TECHNIQUES IN BREAST CANCER RADIOTHERAPY (FAITH): PRELIMINARY RESULTS OF RETROSPECTIVE STUDY
Gowtham Surya Krishnasamy, Maharashtra, Mumbai, India
Supportive care
P40 FEATURES TO LOOK FOR IN A BRA IF YOUR PATIENT HAS LYMPHOEDEMA
Heidi Flaherty, Melbourne, Australia
P41 THE CLOCK STARTS AT DIAGNOSIS: ARE BREAST CANCER PATIENTS IN WESTERN NSW MEETING OPTIMAL TREATMENT TIMEFRAMES?
Sam Guempel-Crothers, Dubbo, Australia
P42 DETERMINANTS OF ACUTE SKIN TOXICITY IN ADJUVANT BREAST AND CHEST WALL RADIOTHERAPY: A REAL WORLD COHORT STUDY OF OVER 1000 PATIENTS
Georgia Harris, Sydney, Australia
P43 PREGNANCY AND POSTPARTUM ASSOCIATED CANCERS: TRANSLATING LIVED EXPERIENCE INTO NATIONAL PRIORITIES FOR EARLIER DIAGNOSIS AND BETTER CARE
Rachelle Panitz, Brisbane, Australia
P44 A FEASIBILITY STUDY: CAN WE USE A SMARTPHONE APPLICATION TO MONITOR ANXIETY IN BREAST CANCER PATIENTS?
Aroosha Safari, Perth, Australia
P45 EVALUATION OF A BIODEGRADABLE SILK FIBROIN MESH DRESSING IN BREAST AND SURGICAL ONCOLOGY PATIENTS: A RETROSPECTIVE PILOT AUDIT
Azra Tabassum, Sydney, Australia
P46 PROVIDER PERSPECTIVES ON A BUNDLED CARE PILOT FOR EARLY-STAGE BREAST CANCER IN THE AUSTRALIAN PRIVATE HEALTH SYSTEM: ADDRESSING FRAGMENTATION AND INTEGRATING SUPPORTIVE CARE
Yvonne Zissiadis, Perth, Australia
Surgery
P47 RETROSPECTIVE REVIEW OF THE MANAGEMENT OF BREAST ABSCESSES WITH PREDICTORS OF SURGICAL INTERVENTION
Andrew Beatty, Brisbane, Australia
P48 WIRE-FREE LOCALISATION REDUCES TIME-TO-SURGERY FOR PATIENTS UNDERGOING BREAST-CONSERVING SURGERY: A COHORT STUDY FOLLOWING IMPLEMENTATION OF SCOUT®
Susan Bell, Brisbane, Australia
P49 MINIMALLY INVASIVE ROBOTIC MASTECTOMY IN THE SETTING OF PRIOR RADIOTHERAPY: A NOVEL APPLICATION
Sandip Bipte, Maharashtra, Mumbai, India
P50 ENDOSCOPIC NIPPLE- AND SKIN-SPARING MASTECTOMY: A PRACTICAL ALTERNATIVE IN RESOURCE-LIMITED SETTINGS
Sandip Bipte, Maharashtra, Mumbai, India
P51 POTENTIAL FOR OMISSION OF SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER: A RETROSPECTIVE ELIGIBILITY AUDIT USING SOUND AND INSEMA TRIAL CRITERIA AT A NEW ZEALAND CENTRE
Morgan Chambers, Bay of Plenty, New Zealand
P52 SINGLE-PORT ENDOSCOPIC NIPPLE-SPARING MASTECTOMY: AN EARLY AUSTRALIAN EXPERIENCE AND DESCRIPTION OF OUR OPERATIVE APPROACH
Nelson Chen, Sydney, Australia
P53 NODE-NEGATIVE AXILLARY CLEARANCE IN BREAST CANCER SURGERY: KEY PERFORMANCE INDICATOR INSIGHTS FROM THE BREASTSURGANZ QUALITY AUDIT
Tamara Crittenden, Adelaide, Australia
P54 IMPACT OF SENTINEL LYMPH NODE BIOPSY ON SHOULDER FUNCTION FOLLOWING WIDE LOCAL EXCISION FOR BREAST CANCER: A RETROSPECTIVE COHORT STUDY
Devlin Elliott, Melbourne, Australia
P55 DEFINING MODERN BREAST PRESERVATION AFTER IPSILATERAL BREAST TUMOUR RECURRENCE: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF REPEAT BREAST-CONSERVING SURGERY USING CONTEMPORARY PARTIAL BREAST RE-IRRADIATION
Mestiyage Gunatilaka, Sydney, Australia
P56 HOW DO DECISION AID TOOLS INFLUENCE DECISION REGRET IN BREAST CANCER SURGERY? A SYSTEMATIC REVIEW
Ruth Hodson, Australia
P57 DECISION REGRET IN BREAST CANCER SURGERY: WHICH SURGICAL DECISIONS DO PATIENTS COME TO REGRET? A SYSTEMATIC REVIEW
Ruth Hodson, Wollongong, Australia
P58 THE MANAGEMENT AND OUTCOMES OF BREAST CANCER AMONG CULTURALLY AND LINGUISTICALLY DIVERSE (CALD) POPULATIONS
Caitlin Lim, Sydney, Australia
P59 ASSESSING FEASIBILITY OF AXILLARY SURGERY DE-ESCALATION IN CLINICALLY NODE NEGATIVE PATIENTS WHO ACHIEVE A PATHOLOGICAL COMPLETE RESPONSE IN THE BREAST FOLLOWING NEOADJUVANT SYSTEMIC THERAPY FOR BREAST CANCER
Kopa Manahi, Melbourne, Australia
P60 ASSESSMENT OF THE USE OF THE HISTOLOG® SCANNER DURING WIDE LOCAL EXCISION OF BREAST CANCER TO REDUCE RE-EXCISION RATES
Sue Hui Ong, Melbourne, Australia
P61 RETROSPECTIVE REVIEW COMPARING OUTCOMES FOR THE USE OF ARTISS FIBRIN SEALANT VS DRAIN MANAGEMENT POST BREAST SURGERY FOR CHRISTCHURCH HOSPITAL
Priyal Patel, Strowan, New Zealand
P62 BREAST CANCER CARE IN AUSTRALIA AND NEW ZEALAND: AN UPDATED REVIEW OF BREASTSURGANZ QUALITY AUDIT COMPLIANCE
Gaik Si Quah, Sydney, Australia
P63 PATIENT PREFERENCES FOR INTRAOPERATIVE TECHNOLOGIES TO REDUCE RE-EXCISION AFTER BREAST-CONSERVING SURGERY
Magdalena Sejka, Melbourne, Australia
P64 MAGSEED VERSUS WIRE-GUIDED LOCALISATION FOR IMPALPABLE BREAST LESIONS IN A MULTI-SURGEON REGIONAL AUSTRALIAN CENTRE
Cameron Sowter, Wagga Wagga, Australia
P65 INTRODUCTION OF MAGTRACE IN A PERIPHERAL CENTRE AND EVALUATION OF LOCALISATION RATES OF MAGTRACE COMPARED TO LYMPHOSCINTIGRAPY AND PATENT BLUE
Aarthi Sritharan, Brisbane, Australia
P66 TRANSITIONING TO STANDALONE INDOCYANINE GREEN FOR SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER: A SINGLE-SURGEON LEARNING CURVE SERIES
Elizabeth Tan, Melbourne, Australia
P67 EVALUATION OF A RADIOISOTOPE-FREE DUAL-TRACER TECHNIQUE USING INDOCYANINE GREEN AND BLUE DYE FOR SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER
Sandamali Thissawalangu, Woodlands, Singapore
P68 BREAST ASYMMETRY FOLLOWING BREAST CANCER TREATMENT: A SYSTEMATIC REVIEW OF ASSESSMENT, PATIENT-REPORTED OUTCOMES AND MANAGEMENT
Kor Woi Tiang, Sydney, Australia
P69 EARLY OUTCOMES OF SCOUT RADAR LOCALISATION FOR BREAST-CONSERVING SURGERY IN AN AUSTRALIAN REGIONAL HOSPITAL
Malcolm Han Tong Zou, Rockhampton, Australia
Survivorship
P70 PROGESTINS IN BREAST CANCER SURVIVORS: A SYSTEMATIC REVIEW
Xinlin Chin, Rockhampton, Australia
P71 SUSTAINED IMPROVEMENTS IN PHYSICAL ACTIVITY AND FATIGUE FOLLOWING AN INDIVIDUALISED EXERCISE PROGRAM INTEGRATED INTO ROUTINE BREAST CANCER CARE: A MIXED-METHODS COHORT STUDY
Maria Michael, Sydney, Australia
P72 REAL-WORLD IMPLEMENTATION AND EFFECTIVENESS OF COMBINED NUTRITION AND EXERCISE INTERVENTIONS FOR BREAST CANCER SURVIVORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Elise Strange, Brisbane, Australia
Triple negative breast cancer
P73 METAL–PHENOLIC NANOMEDICINE SYNERGIZES CHEMODYNAMIC THERAPY, FERROPTOSIS, AND IMMUNOTHERAPY FOR BREAST CANCER TREATMENT
Yuxin Cheng, Shantou, China

 

Skip to content